·HANQUYOU is the China-developed monoclonal antibody(mAb) biosimilar approved in China, the EU and the U.S.·HANQUYOU has been approved in 47 countries and regions with 5,500,000+ units shipped.·Henlius is actively collaborating with global partners to bring its therapeutics to patients worldwide and has licensed HANQUYOU out to ~100 countries and

"In the future, Fosun will continue to firmly advance its globalization strategy, transforming its globalization capability into sustained profit growth." Guo Guangchang, Chairman of Fosun International, said at the 2024 Fosun Semi-Annual Working Meeting on 20 July 2024. "Fosun's globalization is not a strategy which commences today, but has been going on

Fosun Tourism Group (the “Company”, together with its subsidiaries, the “Group”) wishes to inform shareholders (the “Shareholders”) and potential investors of the Company thatbenefiting from the worldwide easing of travel restrictions and the effective implementation of the Company’s strategy, the operations of the Group’s Club Med and Others, A

On 16 July 2024, S&PGlobal held the “Seizing Opportunities to Drive a Sustainable Future - S&P Global Sustainable1 Sustainability Seminar and the Launch of Sustainability Yearbook 2024 (China Edition)” in Beijing. Fosun International Limited (HKEX stock code: 00656, “Fosun International”) was successfully included in S&P Global’s Sustainability Yearbook 2024 (Ch

(Chengdu, China) July 11, 2024, Club Med, the pioneer of premium All-inclusive holiday lifestyle brand, today announcedthe opening of Club Med Joyview Heilongtan Resort. This marks the debut of Club Med Joyview product line intosouthwest China, further expanding Club Med'spresence in Chinese market. Located in Mei Shan City, Sichuan Province, an hour

On the afternoon of 30 June 2024, the Financial Program Center of China Media Group (CMG) officially released the “China ESG (Corporate Social Responsibility) 2024 ESG Action Report” in Beijing, China. The report evaluated 972 listed companies selected from the pool of 6,471 A-share and Hong Kong listed companies to present the ESG traits and trends of Chinese ent

On 1 July, the China-Thailand Cultural Tourism Industry Summit, hosted by the Global Tourism Economy Research Centre (GTERC) and organized by the China Chamber of Tourism and the China Women’s Chamber of Commerce, was held in Bangkok, Thailand. A Chinese delegation of more than 200 business leaders from the Chinese mainland, the Macao Special Administrati

On 24June2024, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.(“Fosun Pharma”; stock code: 600196. SH, 02196. HK) announced its plan to privatise its subsidiary, Shanghai Henlius Biotech, Inc. (“Henlius”; stock code: 02696.HK), by way of merger by absorption.The cash consideration for this merger is HKD24.6 per share, with a premium of approximately 36.67% o

The Fosun ESG Ambassador Week 2024 has recently concluded. The event gathered ESG ambassadors from Fosun's global member companies in Hong Kong to showcase their sustainability initiatives and achievements. The ESG ambassadors engaged in in-depth discussions with local charitable organizations and sustainability teams of financial institutions on topics such as ESG management&